Bound to be a few nervous shorters keen to cover at these levels. Never know when the FDA is going to grant fast track status to other treatments in the pipeline. This is in fact a great time to NOT be partnered with anyone, certainly more bargaining power for Mesoblast & shareholders who hold complete control over the technology.
Certainly going to be significantly increased interest in regenerative medicine in the USA and wouldn't be surprising to see volumes in MESO nasdaq increase this week.
Bound to be a few nervous shorters keen to cover at these...
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.025(1.88%) |
Mkt cap ! $1.547B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.40 | $1.34 | $3.357M | 2.464M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 36216 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 11318 | 12 |
View Market Depth
| Last trade - 15.31pm 07/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |